Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-07-03

AUTHORS

C Ren, S Kumar, D Chanda, L Kallman, J Chen, J D Mountz, S Ponnazhagan

ABSTRACT

Cell-based therapy for cancer is a promising new field. Among cell types that can be used for this purpose, mesenchymal stem cells (MSCs) appear to hold great advantage for reasons including easier propagation in culture, possible genetic modification to express therapeutic proteins and preferential homing to sites of cancer growth upon in vivo transfer. The present study evaluated the potential of genetically modified MSC, constitutively expressing interferon (IFN)-β, in an immunocompetent mouse model of prostate cancer lung metastasis. A recombinant adeno-associated virus (rAAV) encoding mouse IFN-β was constructed and initially tested in vitro for high-level expression and bioactivity of the transgenic protein. MSCs were transduced by the rAAV-IFN-β or green fluorescent protein ex vivo and used as cellular vehicles to target lung metastasis of TRAMP-C2 prostate cancer cells in a therapy model. Cohorts of mice were killed on days 30 and 75 to determine the effect of therapy by measurement of tumor volume, histology, immunohistochemistry, enzyme-linked immunosorbent assay and flow cytometry. Results indicated a significant reduction in tumor volume in lungs following IFN-β-expressing MSC therapy. Immunohistochemistry of the lung demonstrated increased tumor cell apoptosis and decreased tumor cell proliferation and blood vessel counts. A significant increase in the natural kill cell activity was observed following IFN-β therapy correlating the antitumor effect. Systemic level of IFN-β was not significantly elevated from this targeted cell therapy. These data demonstrate the potential of MSC-based IFN-β therapy for prostate cancer lung metastasis. More... »

PAGES

1446-1453

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/gt.2008.101

DOI

http://dx.doi.org/10.1038/gt.2008.101

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044184873

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18596829


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adoptive Transfer", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Movement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dependovirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Vectors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-beta", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mesenchymal Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mesenchymal Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transduction, Genetic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ren", 
        "givenName": "C", 
        "id": "sg:person.01327330450.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327330450.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kumar", 
        "givenName": "S", 
        "id": "sg:person.01102646641.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102646641.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chanda", 
        "givenName": "D", 
        "id": "sg:person.01036662572.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036662572.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kallman", 
        "givenName": "L", 
        "id": "sg:person.0652037550.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652037550.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "J", 
        "id": "sg:person.01144563407.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144563407.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mountz", 
        "givenName": "J D", 
        "id": "sg:person.07550405624.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ponnazhagan", 
        "givenName": "S", 
        "id": "sg:person.0607717541.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607717541.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00262031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039899847", 
          "https://doi.org/10.1007/bf00262031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature06188", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046203017", 
          "https://doi.org/10.1038/nature06188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3302276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026303949", 
          "https://doi.org/10.1038/sj.gt.3302276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35094059", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037507758", 
          "https://doi.org/10.1038/35094059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-006-9449-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040220331", 
          "https://doi.org/10.1007/s10549-006-9449-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/bcr554", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001222099", 
          "https://doi.org/10.1186/bcr554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3300938", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052413818", 
          "https://doi.org/10.1038/sj.gt.3300938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature01322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019336134", 
          "https://doi.org/10.1038/nature01322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00063030-200418060-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018359798", 
          "https://doi.org/10.2165/00063030-200418060-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-9255-2-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039719946", 
          "https://doi.org/10.1186/1476-9255-2-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-07-03", 
    "datePublishedReg": "2008-07-03", 
    "description": "Cell-based therapy for cancer is a promising new field. Among cell types that can be used for this purpose, mesenchymal stem cells (MSCs) appear to hold great advantage for reasons including easier propagation in culture, possible genetic modification to express therapeutic proteins and preferential homing to sites of cancer growth upon in vivo transfer. The present study evaluated the potential of genetically modified MSC, constitutively expressing interferon (IFN)-\u03b2, in an immunocompetent mouse model of prostate cancer lung metastasis. A recombinant adeno-associated virus (rAAV) encoding mouse IFN-\u03b2 was constructed and initially tested in vitro for high-level expression and bioactivity of the transgenic protein. MSCs were transduced by the rAAV-IFN-\u03b2 or green fluorescent protein ex vivo and used as cellular vehicles to target lung metastasis of TRAMP-C2 prostate cancer cells in a therapy model. Cohorts of mice were killed on days 30 and 75 to determine the effect of therapy by measurement of tumor volume, histology, immunohistochemistry, enzyme-linked immunosorbent assay and flow cytometry. Results indicated a significant reduction in tumor volume in lungs following IFN-\u03b2-expressing MSC therapy. Immunohistochemistry of the lung demonstrated increased tumor cell apoptosis and decreased tumor cell proliferation and blood vessel counts. A significant increase in the natural kill cell activity was observed following IFN-\u03b2 therapy correlating the antitumor effect. Systemic level of IFN-\u03b2 was not significantly elevated from this targeted cell therapy. These data demonstrate the potential of MSC-based IFN-\u03b2 therapy for prostate cancer lung metastasis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/gt.2008.101", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2464476", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2476501", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438761", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7143431", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1105638", 
        "issn": [
          "0969-7128", 
          "1476-5462"
        ], 
        "name": "Gene Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "21", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "recombinant adeno-associated virus", 
      "mesenchymal stem cells", 
      "cancer gene therapy", 
      "adeno-associated virus", 
      "potential of MSCs", 
      "possible genetic modification", 
      "cellular vehicles", 
      "gene therapy", 
      "stem cells", 
      "therapeutic proteins", 
      "cell-based therapies", 
      "transgenic protein", 
      "genetic modification", 
      "high-level expression", 
      "enzyme-linked immunosorbent assay", 
      "promising new field", 
      "cell therapy", 
      "MSC therapy", 
      "great advantage", 
      "immunosorbent assay", 
      "TRAMP-C2 prostate cancer cells", 
      "vivo transfer", 
      "mouse IFN", 
      "easy propagation", 
      "new field", 
      "blood vessel counts", 
      "prostate cancer cells", 
      "tumor cell apoptosis", 
      "cell types", 
      "tumor cell proliferation", 
      "ex vivo", 
      "cell apoptosis", 
      "cell proliferation", 
      "cancer cells", 
      "cancer growth", 
      "potential", 
      "antitumor effects", 
      "protein", 
      "lung metastases", 
      "lung metastasis model", 
      "preferential homing", 
      "bioactivity", 
      "cells", 
      "advantages", 
      "tumor volume", 
      "modification", 
      "assays", 
      "therapy model", 
      "metastasis model", 
      "mouse model", 
      "immunocompetent mouse model", 
      "effect of therapy", 
      "cohort of mice", 
      "transfer", 
      "vehicles", 
      "apoptosis", 
      "homing", 
      "expression", 
      "measurements", 
      "vivo", 
      "vessel count", 
      "proliferation", 
      "therapy", 
      "field", 
      "IFN", 
      "day 30", 
      "cell activity", 
      "metastasis", 
      "systemic levels", 
      "growth", 
      "cytometry", 
      "reduction", 
      "interferon", 
      "significant increase", 
      "significant reduction", 
      "lung", 
      "immunohistochemistry", 
      "present study", 
      "volume", 
      "propagation", 
      "sites", 
      "virus", 
      "mice", 
      "effect", 
      "activity", 
      "results", 
      "culture", 
      "cohort", 
      "histology", 
      "cancer", 
      "types", 
      "levels", 
      "increase", 
      "count", 
      "model", 
      "purpose", 
      "study", 
      "data", 
      "reasons", 
      "prostate cancer lung metastasis", 
      "cancer lung metastasis", 
      "rAAV-IFN", 
      "green fluorescent protein ex vivo", 
      "fluorescent protein ex vivo", 
      "protein ex vivo", 
      "natural kill cell activity", 
      "kill cell activity", 
      "targeted cell therapy", 
      "mouse prostate cancer lung metastasis model", 
      "prostate cancer lung metastasis model", 
      "cancer lung metastasis model"
    ], 
    "name": "Cancer gene therapy using mesenchymal stem cells expressing interferon-\u03b2 in a mouse prostate cancer lung metastasis model", 
    "pagination": "1446-1453", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044184873"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/gt.2008.101"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18596829"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/gt.2008.101", 
      "https://app.dimensions.ai/details/publication/pub.1044184873"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_462.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/gt.2008.101"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/gt.2008.101'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/gt.2008.101'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/gt.2008.101'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/gt.2008.101'


 

This table displays all metadata directly associated to this object as RDF triples.

357 TRIPLES      22 PREDICATES      170 URIs      150 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/gt.2008.101 schema:about N03be23617172465fbe85a90fd1dda4d0
2 N0e181ca2b2a64cf0ba48d1227244cad1
3 N1312c28501e044648961bb0e1ad32271
4 N17a6759008e94a74b5b1e1b47506f0e2
5 N1bb20cab84924ce7867877d8c8a06814
6 N1e00a9a15bac4f1abc4b09304f7b3a07
7 N219fbc0fef004d649bc01ef178e54319
8 N2ba273065d984ad9bb06c90db25d995f
9 N2f083b95287d4503877e0050cb9bbe8d
10 N4a4cfab2119a4f15bb4f3467df70de35
11 N65221329cad24caebc02d91272004a22
12 N69679e82f12544118b531b544e7c334b
13 N7758aed4a64b4d20b6f6f900b9c53e8b
14 N7c00d807280345c1a9b3b49b88216536
15 N7d8601e52a15484fa6644e5bd6b25782
16 N83ee1913fe79441687fb766ec15f77eb
17 N89771454688141e2adebcddd3a605ef2
18 Nc79767088d0146b3b08425902f7d5c58
19 Ne122237a056b43b28a075ee29921b8da
20 Ne452a8cc31f245099e1528e066c61fe6
21 Nf52b1289576d4f388835c6a23cb6a388
22 anzsrc-for:06
23 anzsrc-for:0601
24 anzsrc-for:11
25 anzsrc-for:1112
26 schema:author N713284597a6a4ec1bcbb44ba9848f5f7
27 schema:citation sg:pub.10.1007/bf00262031
28 sg:pub.10.1007/s10549-006-9449-8
29 sg:pub.10.1038/35094059
30 sg:pub.10.1038/nature01322
31 sg:pub.10.1038/nature06188
32 sg:pub.10.1038/sj.gt.3300938
33 sg:pub.10.1038/sj.gt.3302276
34 sg:pub.10.1186/1476-9255-2-8
35 sg:pub.10.1186/bcr554
36 sg:pub.10.2165/00063030-200418060-00003
37 schema:datePublished 2008-07-03
38 schema:datePublishedReg 2008-07-03
39 schema:description Cell-based therapy for cancer is a promising new field. Among cell types that can be used for this purpose, mesenchymal stem cells (MSCs) appear to hold great advantage for reasons including easier propagation in culture, possible genetic modification to express therapeutic proteins and preferential homing to sites of cancer growth upon in vivo transfer. The present study evaluated the potential of genetically modified MSC, constitutively expressing interferon (IFN)-β, in an immunocompetent mouse model of prostate cancer lung metastasis. A recombinant adeno-associated virus (rAAV) encoding mouse IFN-β was constructed and initially tested in vitro for high-level expression and bioactivity of the transgenic protein. MSCs were transduced by the rAAV-IFN-β or green fluorescent protein ex vivo and used as cellular vehicles to target lung metastasis of TRAMP-C2 prostate cancer cells in a therapy model. Cohorts of mice were killed on days 30 and 75 to determine the effect of therapy by measurement of tumor volume, histology, immunohistochemistry, enzyme-linked immunosorbent assay and flow cytometry. Results indicated a significant reduction in tumor volume in lungs following IFN-β-expressing MSC therapy. Immunohistochemistry of the lung demonstrated increased tumor cell apoptosis and decreased tumor cell proliferation and blood vessel counts. A significant increase in the natural kill cell activity was observed following IFN-β therapy correlating the antitumor effect. Systemic level of IFN-β was not significantly elevated from this targeted cell therapy. These data demonstrate the potential of MSC-based IFN-β therapy for prostate cancer lung metastasis.
40 schema:genre article
41 schema:inLanguage en
42 schema:isAccessibleForFree true
43 schema:isPartOf N4c220d47784f432883642cd26f076aae
44 N563e4238977e43148ed27a762e63bade
45 sg:journal.1105638
46 schema:keywords IFN
47 MSC therapy
48 TRAMP-C2 prostate cancer cells
49 activity
50 adeno-associated virus
51 advantages
52 antitumor effects
53 apoptosis
54 assays
55 bioactivity
56 blood vessel counts
57 cancer
58 cancer cells
59 cancer gene therapy
60 cancer growth
61 cancer lung metastasis
62 cancer lung metastasis model
63 cell activity
64 cell apoptosis
65 cell proliferation
66 cell therapy
67 cell types
68 cell-based therapies
69 cells
70 cellular vehicles
71 cohort
72 cohort of mice
73 count
74 culture
75 cytometry
76 data
77 day 30
78 easy propagation
79 effect
80 effect of therapy
81 enzyme-linked immunosorbent assay
82 ex vivo
83 expression
84 field
85 fluorescent protein ex vivo
86 gene therapy
87 genetic modification
88 great advantage
89 green fluorescent protein ex vivo
90 growth
91 high-level expression
92 histology
93 homing
94 immunocompetent mouse model
95 immunohistochemistry
96 immunosorbent assay
97 increase
98 interferon
99 kill cell activity
100 levels
101 lung
102 lung metastases
103 lung metastasis model
104 measurements
105 mesenchymal stem cells
106 metastasis
107 metastasis model
108 mice
109 model
110 modification
111 mouse IFN
112 mouse model
113 mouse prostate cancer lung metastasis model
114 natural kill cell activity
115 new field
116 possible genetic modification
117 potential
118 potential of MSCs
119 preferential homing
120 present study
121 proliferation
122 promising new field
123 propagation
124 prostate cancer cells
125 prostate cancer lung metastasis
126 prostate cancer lung metastasis model
127 protein
128 protein ex vivo
129 purpose
130 rAAV-IFN
131 reasons
132 recombinant adeno-associated virus
133 reduction
134 results
135 significant increase
136 significant reduction
137 sites
138 stem cells
139 study
140 systemic levels
141 targeted cell therapy
142 therapeutic proteins
143 therapy
144 therapy model
145 transfer
146 transgenic protein
147 tumor cell apoptosis
148 tumor cell proliferation
149 tumor volume
150 types
151 vehicles
152 vessel count
153 virus
154 vivo
155 vivo transfer
156 volume
157 schema:name Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model
158 schema:pagination 1446-1453
159 schema:productId N3547996ecbd14eb99b3dbf2b64845f36
160 Nb9b68b516d394c79affaddbb793bc33a
161 Nc7a99c4177184dc38ed0bd6f8f76fb0e
162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044184873
163 https://doi.org/10.1038/gt.2008.101
164 schema:sdDatePublished 2022-01-01T18:18
165 schema:sdLicense https://scigraph.springernature.com/explorer/license/
166 schema:sdPublisher Nca15f61af9694e57ab4d7484b62fc7e2
167 schema:url https://doi.org/10.1038/gt.2008.101
168 sgo:license sg:explorer/license/
169 sgo:sdDataset articles
170 rdf:type schema:ScholarlyArticle
171 N03be23617172465fbe85a90fd1dda4d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Mesenchymal Stem Cell Transplantation
173 rdf:type schema:DefinedTerm
174 N0e181ca2b2a64cf0ba48d1227244cad1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Dependovirus
176 rdf:type schema:DefinedTerm
177 N1312c28501e044648961bb0e1ad32271 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Mice, Inbred C57BL
179 rdf:type schema:DefinedTerm
180 N17a6759008e94a74b5b1e1b47506f0e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Mesenchymal Stem Cells
182 rdf:type schema:DefinedTerm
183 N1bb20cab84924ce7867877d8c8a06814 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Transduction, Genetic
185 rdf:type schema:DefinedTerm
186 N1e00a9a15bac4f1abc4b09304f7b3a07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Male
188 rdf:type schema:DefinedTerm
189 N219fbc0fef004d649bc01ef178e54319 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Prostatic Neoplasms
191 rdf:type schema:DefinedTerm
192 N2ba273065d984ad9bb06c90db25d995f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Immunohistochemistry
194 rdf:type schema:DefinedTerm
195 N2f083b95287d4503877e0050cb9bbe8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Mice
197 rdf:type schema:DefinedTerm
198 N3547996ecbd14eb99b3dbf2b64845f36 schema:name doi
199 schema:value 10.1038/gt.2008.101
200 rdf:type schema:PropertyValue
201 N4a4cfab2119a4f15bb4f3467df70de35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Gene Expression
203 rdf:type schema:DefinedTerm
204 N4c220d47784f432883642cd26f076aae schema:volumeNumber 15
205 rdf:type schema:PublicationVolume
206 N514869829f334c7f8a150f5148b71eb4 rdf:first sg:person.07550405624.18
207 rdf:rest Ncc3607d1691846d1a45a0162d3e35459
208 N563e4238977e43148ed27a762e63bade schema:issueNumber 21
209 rdf:type schema:PublicationIssue
210 N65221329cad24caebc02d91272004a22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Adoptive Transfer
212 rdf:type schema:DefinedTerm
213 N69679e82f12544118b531b544e7c334b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Killer Cells, Natural
215 rdf:type schema:DefinedTerm
216 N713284597a6a4ec1bcbb44ba9848f5f7 rdf:first sg:person.01327330450.33
217 rdf:rest Ne0e283d69a6542a5b27187d683bd4544
218 N7758aed4a64b4d20b6f6f900b9c53e8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
219 schema:name Lung Neoplasms
220 rdf:type schema:DefinedTerm
221 N7c00d807280345c1a9b3b49b88216536 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Animals
223 rdf:type schema:DefinedTerm
224 N7d8601e52a15484fa6644e5bd6b25782 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name Interferon-beta
226 rdf:type schema:DefinedTerm
227 N83ee1913fe79441687fb766ec15f77eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
228 schema:name Cell Line, Tumor
229 rdf:type schema:DefinedTerm
230 N89771454688141e2adebcddd3a605ef2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
231 schema:name Lymphocyte Activation
232 rdf:type schema:DefinedTerm
233 N8a6ba3466cc94fb5b953fd6d0a71a25e rdf:first sg:person.0652037550.16
234 rdf:rest N8e31478cd60c46ec924bccd50e7f0c65
235 N8e31478cd60c46ec924bccd50e7f0c65 rdf:first sg:person.01144563407.49
236 rdf:rest N514869829f334c7f8a150f5148b71eb4
237 Nb9b68b516d394c79affaddbb793bc33a schema:name pubmed_id
238 schema:value 18596829
239 rdf:type schema:PropertyValue
240 Nc79767088d0146b3b08425902f7d5c58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
241 schema:name Genetic Therapy
242 rdf:type schema:DefinedTerm
243 Nc7a99c4177184dc38ed0bd6f8f76fb0e schema:name dimensions_id
244 schema:value pub.1044184873
245 rdf:type schema:PropertyValue
246 Nca15f61af9694e57ab4d7484b62fc7e2 schema:name Springer Nature - SN SciGraph project
247 rdf:type schema:Organization
248 Ncc3607d1691846d1a45a0162d3e35459 rdf:first sg:person.0607717541.07
249 rdf:rest rdf:nil
250 Ne0e283d69a6542a5b27187d683bd4544 rdf:first sg:person.01102646641.23
251 rdf:rest Nf326a1b556ea4f5a8d011f83a3542310
252 Ne122237a056b43b28a075ee29921b8da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
253 schema:name Cell Movement
254 rdf:type schema:DefinedTerm
255 Ne452a8cc31f245099e1528e066c61fe6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
256 schema:name Genetic Vectors
257 rdf:type schema:DefinedTerm
258 Nf326a1b556ea4f5a8d011f83a3542310 rdf:first sg:person.01036662572.43
259 rdf:rest N8a6ba3466cc94fb5b953fd6d0a71a25e
260 Nf52b1289576d4f388835c6a23cb6a388 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
261 schema:name Cell Line
262 rdf:type schema:DefinedTerm
263 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
264 schema:name Biological Sciences
265 rdf:type schema:DefinedTerm
266 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
267 schema:name Biochemistry and Cell Biology
268 rdf:type schema:DefinedTerm
269 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
270 schema:name Medical and Health Sciences
271 rdf:type schema:DefinedTerm
272 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
273 schema:name Oncology and Carcinogenesis
274 rdf:type schema:DefinedTerm
275 sg:grant.2438761 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2008.101
276 rdf:type schema:MonetaryGrant
277 sg:grant.2464476 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2008.101
278 rdf:type schema:MonetaryGrant
279 sg:grant.2476501 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2008.101
280 rdf:type schema:MonetaryGrant
281 sg:grant.7143431 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2008.101
282 rdf:type schema:MonetaryGrant
283 sg:journal.1105638 schema:issn 0969-7128
284 1476-5462
285 schema:name Gene Therapy
286 schema:publisher Springer Nature
287 rdf:type schema:Periodical
288 sg:person.01036662572.43 schema:affiliation grid-institutes:grid.265892.2
289 schema:familyName Chanda
290 schema:givenName D
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036662572.43
292 rdf:type schema:Person
293 sg:person.01102646641.23 schema:affiliation grid-institutes:grid.265892.2
294 schema:familyName Kumar
295 schema:givenName S
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102646641.23
297 rdf:type schema:Person
298 sg:person.01144563407.49 schema:affiliation grid-institutes:grid.265892.2
299 schema:familyName Chen
300 schema:givenName J
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144563407.49
302 rdf:type schema:Person
303 sg:person.01327330450.33 schema:affiliation grid-institutes:grid.265892.2
304 schema:familyName Ren
305 schema:givenName C
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327330450.33
307 rdf:type schema:Person
308 sg:person.0607717541.07 schema:affiliation grid-institutes:grid.265892.2
309 schema:familyName Ponnazhagan
310 schema:givenName S
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607717541.07
312 rdf:type schema:Person
313 sg:person.0652037550.16 schema:affiliation grid-institutes:grid.265892.2
314 schema:familyName Kallman
315 schema:givenName L
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652037550.16
317 rdf:type schema:Person
318 sg:person.07550405624.18 schema:affiliation grid-institutes:grid.265892.2
319 schema:familyName Mountz
320 schema:givenName J D
321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18
322 rdf:type schema:Person
323 sg:pub.10.1007/bf00262031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039899847
324 https://doi.org/10.1007/bf00262031
325 rdf:type schema:CreativeWork
326 sg:pub.10.1007/s10549-006-9449-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040220331
327 https://doi.org/10.1007/s10549-006-9449-8
328 rdf:type schema:CreativeWork
329 sg:pub.10.1038/35094059 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037507758
330 https://doi.org/10.1038/35094059
331 rdf:type schema:CreativeWork
332 sg:pub.10.1038/nature01322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019336134
333 https://doi.org/10.1038/nature01322
334 rdf:type schema:CreativeWork
335 sg:pub.10.1038/nature06188 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046203017
336 https://doi.org/10.1038/nature06188
337 rdf:type schema:CreativeWork
338 sg:pub.10.1038/sj.gt.3300938 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052413818
339 https://doi.org/10.1038/sj.gt.3300938
340 rdf:type schema:CreativeWork
341 sg:pub.10.1038/sj.gt.3302276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026303949
342 https://doi.org/10.1038/sj.gt.3302276
343 rdf:type schema:CreativeWork
344 sg:pub.10.1186/1476-9255-2-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039719946
345 https://doi.org/10.1186/1476-9255-2-8
346 rdf:type schema:CreativeWork
347 sg:pub.10.1186/bcr554 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001222099
348 https://doi.org/10.1186/bcr554
349 rdf:type schema:CreativeWork
350 sg:pub.10.2165/00063030-200418060-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018359798
351 https://doi.org/10.2165/00063030-200418060-00003
352 rdf:type schema:CreativeWork
353 grid-institutes:grid.265892.2 schema:alternateName Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA
354 Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA
355 schema:name Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA
356 Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA
357 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...